Effects of Microplastics, Polystyrene, and Polyethylene on Antioxidants, Metabolic Enzymes, HSP-70, and Myostatin Expressions in the Giant River Prawn Macrobrachium rosenbergii: Impact on Survival and Growth.

This study was conducted to understand the biological effects of microplastics (MPs), polystyrene microspheres (PSM), and polyethylene microparticles (PEM) in the juveniles of the giant river prawn, Macrobrachium rosenbergii. The PSM (0.5-1.0 µm) and PEM (30.0-150.0 µm) were separately incorporated into the artificial diets with concentrations of 1, 5, and 10 mg per 100 g. The prawns were fed with these diets for a period of 60 days. Compared with control, the following dose-dependent changes have been recorded in PSM and PEM incorporated feeds fed prawns: declines in the survival rate, length and weight gains; increase in activities of antioxidant enzymes, such as superoxide dismutase, catalase, glutathione s-transferase, and glutathione peroxidase (GPx); elevated concentrations of reduced glutathione (GSH) and malondialdehyde; decreased activities of metabolic enzymes, such as glutamic oxaloacetic transaminase and glutamic pyruvic transaminase; higher total RNA in hepatopancreas (HP) of PSM fed prawns compared with that of PEM; higher total RNA in muscle (MU) of PEM-fed prawns compared with that of PSM; prominent cDNA bands in 150 bp regions; up-regulated heat shock protein (HSP70) gene in HP; down-regulation of HSP70 gene in MU of PSM-fed prawns only; down-regulated myostatin (MSTN) gene. These results suggest that these MPs have affected the survival and growth, activated the antioxidant defense, inhibit the metabolic enzymes, positively regulated the HSP70 gene, and negatively regulated the MSTN gene in M. rosenbergii. Therefore, exposures to PSM and PEM caused biological effects in this species of prawn.

Anti-embolic effect of Taorenchengqi Tang in rats with embolic stroke induced by occluding middle cerebral artery.

OBJECTIVE: To investigate the anti-embolic effect of Taorenchengqi Tang (TRCQT), a formulas from Traditional Chinese Medicine, plus aspirin in rats with embolic stroke induced by selective occlusion of the middle cerebral artery (MCA). Possible side effects of hemorrhagic incident and other bleeding events and anti-platelet effect were also explored. METHODS: Ninety rats were randomly separated into 9 groups (n = 10): group 1 a sham-operated group (n = 10); groups 2 and 3 orally treated with an isovolumetric solvent (distilled water) for 1 and 3 months, followed by thromboembolic occlusion (n = 10); groups 4 and 5 orally treated with aspirin (5 mg/kg) alone for 1 and 3 months, followed by thromboembolic occlusion (n = 10); groups 6 and 7 orally treated with TRCQT (0.5 g/kg) alone for 1 and 3 months, followed by thromboembolic occlusion (n = 10); groups 8 and 9 orally treated with TRCQT plus aspirin for 1 and 3 months, respectively followed by thromboembolic occlusion (n = 10). The ischemic stroke in rats was induced by selective MCA occlusion. One was orally administered. After the treatments, rats' brains were removed, sectioned and stained with triphenyltetrazolium chloride (TTC) for infarct volume measurement. The incidence of subarachnoid hemorrhage (SAH) and intracerebral hemorrhage (ICH) were observed. A potential gastric bleeding side effect was assessed by measuring hemoglobin (Hb), and prothrombin time (PT). Collagen-induced platelet activation and tail vein bleeding time were measured. RESULTS: Treatment with TRCQT alone or in combination with aspirin reduced infarct volume for 1 (P < 0.05), and 3 (P < 0.01) months without SAH and ICH incidences, and gastric bleeding. TRCQT treatment for 1 month was also not altered PT. Moreover, a concentration dependent inhibition of collagen-induced platelet activation, followed by increasing of tail vein bleeding time was observed after TRCQT treatment. CONCLUSION: Either TRCQT alone or TRCQT plus aspirin exhibits potent neuroprotective effect by reducing infarct volume without changing the status of SAH, ICH and gastric bleeding possibly via inhibiting the platelet activation and increasing bleeding time.

Chinese medicines and bioactive compounds for treatment of stroke / 中国结合医学杂志

Stroke is an important cause of mortality and morbidity worldwide but effective therapeutic strategy for the prevention of brain injury in patients with cerebral ischemia is lacking. Although tissue plasminogen activator has been used to treat stroke patients, this therapeutic strategy is confronted with ill side effects and is limited to patients within 3 h of a stroke. Due to the complexity of the events and the disappointing results from single agent trials, the combination of thrombolytic therapy and effective neural protection therapy may be an alternative strategy for patients with cerebral ischemia. Chinese medicine (CM) is the most widely practiced form of herbalism worldwide, as it is a sophisticated system of medical theory and practice that is specifically different from Western medicine. Most traditional therapeutic formulations consist of a combination of several drugs. The combination of multiple drugs is thought to maximize therapeutic efficacy by facilitating synergistic actions and preventing possible adverse effects while at the same time marking at multiple targets. CM has been labeled in ancient medicine systems as a treatment for various diseases associated with stroke. This review summarizes various CMs, bioactive compounds and their effects on cerebral ischemia.

Protective effect of Actiniopteris radiata (Sw.) Link. against CCl4 induced oxidative stress in albino rats.

ETHNOPHARMACOLOGICAL RELEVANCE: Actiniopteris radiata is a herb with great medicinal value and is evaluated for hepatoprotective activity. To investigate the protective effect of ethanolic extract of Actiniopteris radiata (EEAR) on CCl4 induced oxidative stress in male Wistar albino rats. MATERIALS AND METHODS: EEAR were administered for 8 consecutive weeks to rats. Group I - control; Group II - toxin control (30% CCl4); Group III and Group IV received EEAR (250 and 500 mg/kg respectively). Antioxidant status in liver were estimated by determining the activities of the antioxidant enzymes, superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPx); as well as by determining the levels of lipid peroxidation (LPO) and reduced glutathione (GSH). In addition, isoenzyme pattern and mRNA expression of the antioxidants were studied. Partial characterization of EEAR was performed by Liquid chromatography-mass spectrometry (LC-MS). RESULTS: CCl4 induced oxidative stress as evidenced from increase in LPO along with reduction of SOD, CAT, GPx and GSH. Treatment with EEAR (250 and 500 mg/kg) mitigated the CCl4 induced oxidative stress. An analysis of the isozyme pattern of these antioxidant enzymes revealed variations in SOD2, CAT, GPx2 and GPx3 in CCl4 treated rats, which were normalized after EEAR treatment. Furthermore, expression of genes for the antioxidant enzymes, were down-regulated by CCl4 treatment, which were reversed by EEAR. The results of partial characterization of EEAR by LC-MS revealed the presence of rutin and other 7 unknown phenolic derivatives. CONCLUSIONS: These findings suggest the protective effect of EEAR against CCl4 induced oxidative stress might be attributed to the presence of flavonoids and phenolic compounds.